Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-10-13 VIVO VENTURES VII, LLC 10% owner Conversion · Series C Preferred Stock −1,346,068 0
2015-10-13 VIVO VENTURES VII, LLC 10% owner Conversion · Series C Preferred Stock −29,337 0
2015-10-13 Mehra Anand Director Conversion +1,880,390 1,880,390
2015-10-13 Mehra Anand Director Purchase +409,090 $11.00 $4.5M 2,289,480
2015-10-13 Mehra Anand Director Conversion · Series A Preferred Stock −2,000,000 0
2015-10-13 Mehra Anand Director Conversion · Series B Preferred Stock −2,424,242 0
2015-10-13 Mehra Anand Director Conversion · Series C Preferred Stock −2,063,107 0
2015-10-13 Sofinnova Venture Partners VIII, L.P. 10% owner Conversion +1,880,390 1,880,390
2015-10-13 Sofinnova Venture Partners VIII, L.P. 10% owner Purchase +409,090 $11.00 $4.5M 2,289,480
2015-10-13 Sofinnova Venture Partners VIII, L.P. 10% owner Conversion · Series A Preferred Stock −2,000,000 0
2015-10-13 Sofinnova Venture Partners VIII, L.P. 10% owner Conversion · Series B Preferred Stock −2,424,242 0
2015-10-13 Sofinnova Venture Partners VIII, L.P. 10% owner Conversion · Series C Preferred Stock −2,063,107 0
2015-10-13 Ali-Jackson Kamil Chief Legal Officer Conversion +3,738 24,027
2015-10-13 Ali-Jackson Kamil Chief Legal Officer Conversion · Series A Preferred Stock −10,000 0
2015-10-13 Ali-Jackson Kamil Chief Legal Officer Conversion · Series B Preferred Stock −2,901 0
2015-10-13 Ruffo Frank Chief Financial Officer Conversion +7,478 137,912
2015-10-13 Ruffo Frank Chief Financial Officer Conversion · Series A Preferred Stock −20,000 0
2015-10-13 Ruffo Frank Chief Financial Officer Conversion · Series B Preferred Stock −5,802 0
2015-10-13 Tullman Stephen A. Director Conversion +46,188 394,014
2015-10-13 Tullman Stephen A. Director Conversion · Series A Preferred Stock −110,000 0

Page 56 of 57 · 1,130 trades